Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion type Assertion NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_head.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion description "[Similarly NKX2-5, SPOCK2, SLC16A12, DPYS and GALR2 are candidate biomarkers for colon cancer (methylation range 60%-95%) and GALR2 hypermethylation showed a sensitivity of 85% and specificity of 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion evidence source_evidence_literature NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion SIO_000772 18446232 NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion wasDerivedFrom befree-2016 NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion wasGeneratedBy ECO_0000203 NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.